Lecture looking ahead – Potential barriers to immune checkpoint inhibitors use in MIBC

What are the main barriers to immune checkpoint inhibitor use in muscle-invasive bladder cancer? Prof. Shahrokh Shariat (AT) discusses this in this newest edition of the ESOU Online MIBC serie.